Logos Global Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $16M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $15.3M | Sell |
|
|||||
|
2024
Q1 | $47M | Sell |
|
|||||
|
2023
Q4 | $56.9M | Buy |
|
|||||
|
2023
Q3 | $28.5M | Buy |
|
|||||
|
2023
Q2 | $56.9M | Sell |
|
|||||
|
2023
Q1 | $52.8M | Sell |
|
|||||
|
2022
Q4 | $69.8M | Buy |
|
|||||
|
2022
Q3 | $88.8M | Sell |
|
|||||
|
2022
Q2 | $67.8M | Buy |
|
|||||
|
2022
Q1 | $45.7M | Sell |
|
|||||
|
2021
Q4 | $47.3M | Sell |
|
|||||
|
2021
Q3 | $47.8M | Buy |
|
|||||
|
2021
Q2 | $22.1M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $17.2M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $18M | Buy |
|